Biosimilars of Monoclonal Antibodies

Discover the essential guide to the science and development of biosimilars with "Biosimilars of Monoclonal Antibodies" by Cheng Liu. Published by John Wiley & Sons Inc in 2017, this comprehensive hardback spans 704 pages, offering in-depth insights into the complex world of monoclonal antibody (mAb) biosimilars. This book addresses the significant need for detailed knowledge in this rapidly evolving field, covering every aspect of biosimilar development, including preclinical and clinical studies, regulatory considerations, and manufacturing processes. Whether you are a researcher, healthcare professional, or industry expert, this resource will enhance your understanding and facilitate your work in developing effective biosimilars. Enhance your library with this indispensable text and stay at the forefront of biopharmaceutical innovation.